Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2777
-0.0123 (-4.24%)
Apr 27, 2026, 12:07 PM EDT - Market open
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $44.33 million as of April 27, 2026. Its market cap has decreased by -85.33% in one year.
Market Cap
44.33M
Enterprise Value
5.50M
1-Year Change
-85.33%
Ranking
Category
Stock Price
$0.28
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $44.33M, a decrease of -64.49%. That is a compound annual growth rate of -13.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 24, 2026 | 46.29M | -30.19% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Atossa Therapeutics | 49.08M |
| Nutriband | 48.57M |
| Telomir Pharmaceuticals | 48.13M |
| Xilio Therapeutics | 48.05M |
| Hyperion DeFi | 47.50M |
| Rein Therapeutics | 46.54M |
| Dogwood Therapeutics | 46.09M |
| Rallybio | 45.65M |